PMID- 37560268
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230811
IS  - 1880-4276 (Print)
IS  - 1883-2148 (Electronic)
IS  - 1880-4276 (Linking)
VI  - 39
IP  - 4
DP  - 2023 Aug
TI  - Heart failure is associated with increased risk of all-cause mortality after 
      transvenous lead extraction: A systematic review and meta-analysis.
PG  - 596-606
LID - 10.1002/joa3.12880 [doi]
AB  - BACKGROUND: Transvenous lead extraction (TLE) is increasingly considered in 
      cardiac implantable electronic device management. Heart failure (HF) might be 
      associated with mortality risks after the TLE procedure. This study aims to 
      assess mortality risk in HF patients undergoing TLE. METHOD: We searched MEDLINE 
      and Embase databases from inception to June 2022 to identify articles that 
      included patients with and without HF who underwent TLE, which reported mortality 
      in both groups. The pooled effect size was calculated with a random-effects model 
      and 95% CI to compare post-TLE mortality between the two groups. RESULTS: Eleven 
      studies were included in the analysis. Each left ventricular ejection fraction 
      (LVEF) increased by 1% was associated with reduced mortality by 2% (HR = 0.98, 
      95% CI: 0.97-0.99, I (2) = 74.9%, p < .01). The presence of HF compared to those 
      without HF was associated with higher mortality rates (OR: 3.04, 95% CI: 
      2.56-3.61, I (2) = 0.0%, p < .531). There was a significant increase in the 
      mortality rates in patients with New York Heart Association (NYHA) function class 
      III (OR: 2.29, 95% CI: 1.29-4.06, I (2) = 0.0%, p = .498) and NYHA IV (OR: 8.5, 
      95% CI: 2.98-24.3, I (2) = 0.0%, p = .997). CONCLUSIONS: Our study found that 
      post-TLE mortality decreases by 2% as LVEF increases by 1%, also mortality is 
      higher in patients with NYHA III and IV.
CI  - (c) 2023 The Authors. Journal of Arrhythmia published by John Wiley & Sons 
      Australia, Ltd on behalf of Japanese Heart Rhythm Society.
FAU - Talaei, Fahimeh
AU  - Talaei F
AUID- ORCID: 0000-0001-9236-4837
AD  - Department of Internal Medicine McLaren Flint Hospital Flint Michigan USA.
AD  - Department of Cardiovascular Diseases Mayo Clinic Phoenix Arizona USA.
FAU - Tan, Min C
AU  - Tan MC
AUID- ORCID: 0000-0002-7682-8934
AD  - Department of Cardiovascular Diseases Mayo Clinic Phoenix Arizona USA.
AD  - Department of Internal Medicine New York Medical College at Saint Michael's 
      Medical Center Newark New Jersey USA.
FAU - Trongtorsak, Angkawipa
AU  - Trongtorsak A
AUID- ORCID: 0000-0003-1855-029X
AD  - Department of Cardiovascular Medicine Virginia Commonwealth University Richmond 
      Virginia USA.
FAU - Lee, Justin Z
AU  - Lee JZ
AD  - Department of Cardiovascular Diseases Mayo Clinic Phoenix Arizona USA.
AD  - Department of Cardiovascular Medicine Cleveland Clinic Cleveland Ohio USA.
FAU - Rattanawong, Pattara
AU  - Rattanawong P
AUID- ORCID: 0000-0001-9419-5854
AD  - Demoulas Center for Cardiac Arrhythmias Massachusetts General Hospital Harvard 
      Medical School Boston Massachusetts USA.
LA  - eng
PT  - Journal Article
DEP - 20230606
PL  - Japan
TA  - J Arrhythm
JT  - Journal of arrhythmia
JID - 101263026
PMC - PMC10407184
OTO - NOTNLM
OT  - heart failure
OT  - left ventricular ejection fraction
OT  - mortality
OT  - transvenous lead extraction
COIS- All authors have no relationships relevant to the contents of this paper to 
      disclose.
EDAT- 2023/08/10 06:43
MHDA- 2023/08/10 06:44
PMCR- 2023/06/06
CRDT- 2023/08/10 04:26
PHST- 2022/12/12 00:00 [received]
PHST- 2023/05/17 00:00 [revised]
PHST- 2023/05/24 00:00 [accepted]
PHST- 2023/08/10 06:44 [medline]
PHST- 2023/08/10 06:43 [pubmed]
PHST- 2023/08/10 04:26 [entrez]
PHST- 2023/06/06 00:00 [pmc-release]
AID - JOA312880 [pii]
AID - 10.1002/joa3.12880 [doi]
PST - epublish
SO  - J Arrhythm. 2023 Jun 6;39(4):596-606. doi: 10.1002/joa3.12880. eCollection 2023 
      Aug.